Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Elpis Biopharmaceuticals

Request full access

Developing oncology protein degrading therapeutics

Lexington, United StatesFounded 2017

About Elpis Biopharmaceuticals

Elpis Biopharmaceuticals operates in the biopharmaceutical sector, focusing on the development of advanced cancer therapies. The company leverages its proprietary mSCAFoldTM technology to engineer cytokines and chemokines that stimulate immune cells, such as NK cells and cytotoxic T cells, to target and eradicate tumor lesions. Additionally, Elpis is developing bispecific antibodies designed to recognize multiple tumor surface antigens and activate immune cells, addressing the complex pathogenesis of cancer driven by various signaling pathways and genetic alterations. The company primarily serves the oncology market, aiming to provide effective therapeutic solutions for cancer patients. Elpis Biopharmaceuticals generates revenue through the development and potential commercialization of its proprietary cancer therapies. Key clients include healthcare providers and institutions involved in cancer treatment.

Source: Dealroom company data

At a glance

Status
Operational
Employees
11
Open positions
None listed
Dealroom signal
66.7/100
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2020 $30M $120M Undisclosed —
DEBT✓Debt May 2020 $150K — U.S. Small Business Administration —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Elpis Biopharmaceuticals website traffic

Latest recorded traffic for Elpis Biopharmaceuticals is 2.2K monthly website visits, up 400% over the last three months. Elpis Biopharmaceuticals's team declined 8.3% over the past year.

Latest monthly visits2.2K 3-month web change+400% 1-year team growth-8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Elpis Biopharmaceuticals in the Lexington ecosystem

Live from Dealroom

The Elpis Biopharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • U.S. Small Business Administration
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States80%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Elpis Biopharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Elpis Biopharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.